| Bioactivity | SARS-CoV-2-IN-38 (compound 24) is a SARS-CoV-2 inhibitor with good oral bioavailability in mice (F%=39.75%)[1]. |
| Target | SARS-CoV-2. |
| Name | SARS-CoV-2-IN-38 |
| CAS | 2882823-27-8 |
| Formula | C18H14ClF4NO4 |
| Molar Mass | 419.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li R, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. |